TipRanks on MSN

Regeneron’s New Parkinson’s Study: A Potential Game-Changer?

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is conducting a ...
ScienceAlert on MSN

Parkinson's Discovery Suggests We May Have an FDA-Approved Treatment Already

Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...
Business Wire

Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease

Data from Phase IIb PADOVA study and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease Prasinezumab is a potential first-in-class ...
Medscape

Novel Drug With New Mechanism Promising for Parkinson’s Motor Fluctuations

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
PMLive

Mission Therapeutics advances Parkinson’s disease candidate

Mission Therapeutics, a clinical-stage biotechnology company, has raised $13.3m to advance the clinical development of its ...